About Us

Diagnostic HYBRIDS innovates, develops, manufactures and markets cellular and molecular diagnostic kits for various applications in detecting a wide range of respiratory diseases, herpes infections, thyroid function, and other high value markers of disease. Our products provide an accurate, rapid and cost-effective diagnosis, and our products are changing the way people use technologies to more effectively diagnose and treat respiratory and other diseases. We strive to address a variety of health issues, impacting the quality of healthcare outcomes and the quality of life.

Diagnostic HYBRIDS is committed to providing quality products and exceptional service to our customers through teamwork, regulatory compliance, process control, and continual Quality Management System improvement. The company is certified to ISO 13485 standards, a testament to the quality and care that go into manufacturing and servicing our product lines.

History

Diagnostic HYBRIDS was founded in 1983 by successful biomedical entrepreneur Wilfred R. Konneker, Ph.D., in collaboration with Ohio University Professors Joseph Jollick, Ph.D., and Thomas E. Wagner, Ph.D., who led the OU research team that developed the world's first transgenic animal. Through our tenacity, optimism, and discipline we continue to develop innovative research. The company is privately held.

Our Logo

Diagnostic HYBRIDS is best known for its core strength in innovative technology development. Not surprisingly, our brand image represents our strong science core through the antibody-antigen reaction and the double helix of a nucleic acid molecule interwoven with rapid movement of the biologic human form.

For our associates, Integrating Science and Humanity best describes how we tie our overall strategic vision with our ultimate tactical goals - to align each product or technology that we explore, develop and manufacture to our most important corporate goal of positively impacting humanity!